COSCIENS Biopharma Inc.
COSCIENS Biopharma Inc. scores highest on Price (46) and lowest on Earnings (0). Its PosiPenta is 27.32 out of 100, weaker than most similar companies.
On the Penta Grid this week, COSCIENS Biopharma Inc. is Grid #8 of 9 in Canada.
Compared with similar companies in the Healthcare sector in Canada.
The five pillars
Details
PPrice
| P/E ratio | -1.49 |
| P/B ratio | 0.41 |
EEarnings
| Trailing EPS | ₹-386.69 |
| Forward EPS | — |
NNitro
| Price | 576.29 |
| 52-week high | 2691.17 |
| 52-week low | 475.71 |
| Fall from 52-week high | 78.6% |
TTorque
| Return on equity (ROE) | -52.83% |
| Debt-to-equity | 0.13 |
AAnchor
| Beta (price swings) | 1.80 |
| Market cap | ₹57 Cr |
| Insider holding | 27.53% |
| Dividend yield | 0.00% |
Figures as used for the week of 24 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is COSCIENS Biopharma Inc.'s PosiPenta score?
COSCIENS Biopharma Inc.'s PosiPenta is 27.32 out of 100 for the week of 24 Oct 2026, based on 5 of 5 pillars.
Where does COSCIENS Biopharma Inc. stand on the Penta Grid?
On the Penta Grid this week, COSCIENS Biopharma Inc. is Grid #8 of 9 in Canada.
Which PosiPenta pillar is strongest for COSCIENS Biopharma Inc.?
Price (valuation), with a score of 46 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for COSCIENS Biopharma Inc.?
Earnings (growth), with a score of 0 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.